AI assistant
Sending…
STEPAN CO — Director's Dealing 2014
Aug 26, 2014
32175_dirs_2014-08-26_4dab5272-9fc0-497c-a54c-4d01e873ed74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEPAN CO (SCL)
CIK: 0000094049
Period of Report: 2014-08-22
Reporting Person: PACHOLEC FRANK (Vice President R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-22 | Common Stock | M | 500.000 | $18.46 | Acquired | 56992.803 | Direct |
| 2014-08-22 | Common Stock | S | 93.000 | $48.330 | Disposed | 56899.803 | Direct |
| 2014-08-22 | Common Stock | S | 107.000 | $48.370 | Disposed | 56792.803 | Direct |
| 2014-08-22 | Common Stock | S | 300.000 | $48.380 | Disposed | 56492.803 | Direct |
| 2014-08-25 | Common Stock | M | 500.000 | $18.460 | Acquired | 56992.803 | Direct |
| 2014-08-25 | Common Stock | S | 100.000 | $48.240 | Disposed | 56892.803 | Direct |
| 2014-08-25 | Common Stock | S | 200.000 | $48.280 | Disposed | 56692.803 | Direct |
| 2014-08-25 | Common Stock | S | 200.000 | $48.300 | Disposed | 56492.803 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-08-22 | Employee Stock Option (Right to Buy) | $18.460 | M | 500.00 | Disposed | 2017-02-09 | Common Stock (500.000) | Direct |
| 2014-08-25 | Employee Stock Option (Right to Buy) | $18.460 | M | 500.00 | Disposed | 2017-02-09 | Common Stock (500.000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1615.755 | Indirect |
More from STEPAN CO
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 23